Tatva Chintan Pharma Chem Limited

NSE:TATVA.NS

856.35 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017
Revenue 3,935.044,236.124,312.932,968.572,576.852,024.491,337
Cost of Revenue 2,545.482,261.012,076.781,554.661,384.41,163.011,015.41
Gross Profit 1,389.561,975.112,236.151,413.911,192.45861.48321.59
Gross Profit Ratio 0.3530.4660.5180.4760.4630.4260.241
Reseach & Development Expenses 79.4260.3937.072.7910.141.991.89
General & Administrative Expenses 58.950.6743.8422.9322.7439.530
Selling & Marketing Expenses 225.13287.66338.26191.88170.23159.210
SG&A 963.65404.76382.1214.81192.97198.74132.62
Other Expenses 75.0957.441.334.5453.130.39-2.04
Operating Expenses 963.651,464.851,228.22807.89656.24541.05136.55
Operating Income 425.91584.691,004.84601.81532.5317185.04
Operating Income Ratio 0.1080.1380.2330.2030.2070.1570.138
Total Other Income Expenses Net 9.77-139.0436.373.95-56.53-43.075.3
Income Before Tax 435.68447.791,041.21606.96475.97273.93190.34
Income Before Tax Ratio 0.1110.1060.2410.2040.1850.1350.142
Income Tax Expense 132.14-7.0882.4784.3498.0868.567.45
Net Income 303.54454.87958.74522.62377.89205.43122.89
Net Income Ratio 0.0770.1070.2220.1760.1470.1010.092
EPS 13.2620.5244.5926.0218.8110.236.12
EPS Diluted 13.2620.5244.5926.0218.8110.236.12
EBITDA 681.96663.251,166.14714.69562.18339.42214.56
EBITDA Ratio 0.1730.1570.270.2410.2180.1680.16